These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23173763)

  • 1. Assessment of left ventricular geometrical patterns and function among hypertensive patients at a tertiary hospital, Northern Tanzania.
    Silangei LK; Maro VP; Diefenthal H; Kapanda G; Dewhurst M; Mwandolela H; Hamel B
    BMC Cardiovasc Disord; 2012 Nov; 12():109. PubMed ID: 23173763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geometrical and functional changes of left heart in adults with prehypertension and hypertension: a cross-sectional study from China.
    Li T; Yang J; Guo X; Chen S; Sun Y
    BMC Cardiovasc Disord; 2016 May; 16():114. PubMed ID: 27234840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive characterisation of hypertensive heart disease left ventricular phenotypes.
    Rodrigues JC; Amadu AM; Dastidar AG; Szantho GV; Lyen SM; Godsave C; Ratcliffe LE; Burchell AE; Hart EC; Hamilton MC; Nightingale AK; Paton JF; Manghat NE; Bucciarelli-Ducci C
    Heart; 2016 Oct; 102(20):1671-9. PubMed ID: 27260191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factors of abnormal left ventricular geometrical patterns in untreated hypertensive patients.
    Li H; Pei F; Shao L; Chen J; Sun K; Zhang X; Zhang C; Liu J; Xiao C; Hui R
    BMC Cardiovasc Disord; 2014 Oct; 14():136. PubMed ID: 25280487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study.
    Bang CN; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Roman MJ; Køber L; Wachtell K; Devereux RB
    J Hypertens; 2013 Oct; 31(10):2060-8. PubMed ID: 23838656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Chamber Dilatation on the Prognostic Value of Left Ventricular Geometry in Hypertension.
    Verdecchia P; Angeli F; Mazzotta G; Bartolini C; Garofoli M; Aita A; Poltronieri C; Pinzagli MG; Valecchi F; Martone S; Ramundo E; Turturiello D; Reboldi G
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28539381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors for left ventricular hypertrophy and left ventricular geometric abnormality in the patients with hypertension among Han Chinese.
    Wang SX; Xue H; Zou YB; Sun K; Fu CY; Wang H; Hui RT
    Chin Med J (Engl); 2012 Jan; 125(1):21-6. PubMed ID: 22340460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of different left ventricular geometric patterns on right ventricular deformation and function in hypertensive patients.
    Tadic M; Cuspidi C; Vukomanovic V; Kocijancic V; Celic V
    Arch Cardiovasc Dis; 2016 May; 109(5):311-20. PubMed ID: 27020514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
    Bang CN; Gerdts E; Aurigemma GP; Boman K; de Simone G; Dahlöf B; Køber L; Wachtell K; Devereux RB
    Circ Cardiovasc Imaging; 2014 May; 7(3):422-9. PubMed ID: 24723582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of hypertension with or without diabetes on left ventricular remodeling in rural Chinese population: a cross-sectional study.
    Li T; Chen S; Guo X; Yang J; Sun Y
    BMC Cardiovasc Disord; 2017 Jul; 17(1):206. PubMed ID: 28750662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial hypertension, left ventricular geometry and QT dispersion in a middle-aged Estonian female population.
    Shipilova T; Pshenichnikov I; Kaik J; Volozh O; Abina J; Kalev M; Lass J; Karai D
    Blood Press; 2003; 12(1):12-8. PubMed ID: 12699130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and determinants of left ventricular hypertrophy and remodelling patterns in hypertensive patients: the St. Petersburg study.
    Conrady AO; Rudomanov OG; Zaharov DV; Krutikov AN; Vahrameeva NV; Yakovleva OI; Alexeeva NP; Shlyakhto EV
    Blood Press; 2004; 13(2):101-9. PubMed ID: 15182113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular and atrial remodelling in hypertensive patients using thresholds from international guidelines and EMINCA data.
    Sheng Y; Li M; Xu M; Zhang Y; Xu J; Huang Y; Li X; Yao G; Sui W; Zhang M; Zhang Y; Zhang C; Zhang Y; Zhang M
    Eur Heart J Cardiovasc Imaging; 2022 Jan; 23(2):166-174. PubMed ID: 34718487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of and risk factors for abnormal left ventricular geometrical patterns in hypertensive subjects administered irbesartan.
    Huang C; Huang Y; Zhong Q; Cai A; Feng YQ
    J Clin Lab Anal; 2021 Mar; 35(3):e23688. PubMed ID: 33389756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of left ventricular geometry and function to systemic hemodynamics in hypertension: the LIFE Study. Losartan Intervention For Endpoint Reduction in Hypertension Study.
    Bella JN; Wachtell K; Palmieri V; Liebson PR; Gerdts E; Ylitalo A; Koren MJ; Pedersen OL; Rokkedal J; Dahlöf B; Roman MJ; Devereux RB
    J Hypertens; 2001 Jan; 19(1):127-34. PubMed ID: 11204292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy.
    Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Gattobigio R; Zampi I; Santucci A; Santucci C; Reboldi G; Porcellati C
    Am J Cardiol; 1996 Jul; 78(2):197-202. PubMed ID: 8712142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular dysfunction assessed by cardiac time interval analysis among different geometric patterns in untreated hypertension.
    Takasaki K; Miyata M; Imamura M; Yuasa T; Kuwahara E; Kubota K; Kono M; Ueya N; Horizoe Y; Chaen H; Mizukami N; Kisanuki A; Hamasaki S; Tei C
    Circ J; 2012; 76(6):1409-14. PubMed ID: 22447013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study). Losartan Intervention For Endpoint.
    Wachtell K; Rokkedal J; Bella JN; Aalto T; Dahlöf B; Smith G; Roman MJ; Ibsen H; Aurigemma GP; Devereux RB
    Am J Cardiol; 2001 Jan; 87(1):54-60. PubMed ID: 11137834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study.
    Devereux RB; Bella J; Boman K; Gerdts E; Nieminen MS; Rokkedal J; Papademetriou V; Wachtell K; Wright J; Paranicas M; Okin PM; Roman MJ; Smith G; Dahlöf B
    Blood Press; 2001; 10(2):74-82. PubMed ID: 11467763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.